References
Maertens JA, Raad II, Marr KA, Patterson TF Kontoyiannis DP, Cornely O, Bow EJ, Rahay G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Sellesiang D, Shoham S, Thompson GR LM 3rd, Maher RM, Schmitt-Hoffmann AH, Ullmann AJ ZB (2016) Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomized controlled, non inferiority trial. Lancet 387:760–769
Marty FM, Ostrosky-Zeichner L, Cornely OA, Mullane KM, Perfect JR, Thompson GR 3rd, Alangaden GJ, Brown JM, Fredricks DN, Heinz WJ, Herbrecht R, Klimko N, Klyyasova G, Maertens JA, Melinkeri SR, Oren I, Pappas PG, Ráčil Z, Rahav G, Santos R, Schwartz S, Vehreschild JJ, Young JH, Chetchotisakd P, Jaruratanasirikul S, Kanj SS, Engelhardt M, Kaufhold A, Ito M, Lee M, Sasse C, Maher RM, Zeiher B, MjGT V, VITAL and Fungi Scope Mucormycosis Invesigators (2016) Isavuconazole treatment for mucormycosis: a singlearm open-label trial and case-control analysis. Lancet Infect Dis 16:828–837
Pettit NN, Carver PL (2015 Jul) Isavuconazole: a new option for the management of invasive fungal infections. Ann Pharmacother 49(7):825–842
Dutch Working Party on Antibiotic Policy. SWAB Guidelines for the Management of Invasive Fungal Infections. Revised version. Released: 14 December 2017. Available at http://www.swab.nl/swab/cms3.nsf/uploads/3AA7A56CE879587BC12581F80061297F/$FILE/SWAB%20Richtlijn%20Mycosen%202017%20(final).pdf (last access, January 31, 2018)
Wilby KJ. A review of the clinical pharmacokinetics and pharmacodynamics of isavuconazole. Eur J Drug Metab Pharmacokinet 2017 [Epub ahead of print]
Funding
This work was supported by internal funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
ESM 1
(DOCX 18 kb)
Rights and permissions
About this article
Cite this article
Arsiè, E., Piconi, S., Iavarone, M. et al. High isavuconazole plasma levels in a patient with possible invasive pulmonary aspergillosis and cirrhosis. Eur J Clin Pharmacol 74, 1089–1090 (2018). https://doi.org/10.1007/s00228-018-2462-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-018-2462-0